» Articles » PMID: 25028645

Serum HDL-C Level of Iranian Adults: Results from Sixth National Surveillance of Risk Factors of Non-Communicable Disease

Overview
Specialty Endocrinology
Date 2014 Jul 17
PMID 25028645
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Reduced level of high-density lipoprotein-cholesterol (HDL-C) is shown to be in association with the risk of coronary artery disease (CAD), metabolic syndrome, and chronic renal disease. Lack of a national representative research for assessing the level of HDL-C among Iranian adults, which is essential for health policy makers, was the motivation for this study.

Methods: HDL-C levels of 4,803 Iranian adults aged 25-64 years old were measured by sixth national Surveillance of Risk Factors of Non-Communicable Disease (SuRFNCD) in 2011. Data were entered into STATA 12 software and were analyzed using fractional polynomial model and other statistical methods.

Results: In average, Iranian adult women had 5.8 ± 0.3 mg/dL higher HDL-C level than men. The analysis showed that the HDL-C levels will be changed at most 3 mg/dL from the age of 25 to 64 years. Furthermore, it was shown that approximately half of the men and one third of the women had HDL-C level less than 40 mg/DL. Also HDL-C level of more than 60% of the women was less than 50 mg/dL.

Conclusions: High level of HDL-C among Iranian adults was shown in this study which can be a major reason of increasing incidence of heart diseases in Iran. Hence, formulating policy regulations and interventions in Iranian lifestyle to reduce HDL-C levels should be among top priorities for health politicians.

Citing Articles

Is there an independent association between metabolic syndrome and smoking in Iranian adults? Results of a large multicenter national survey.

Meysamie A, Ghalehtaki R, Ghodsi S, Mohebi M, Ghalehtaki S, Salarvand F Caspian J Intern Med. 2021; 12(3):327-335.

PMID: 34221284 PMC: 8223050. DOI: 10.22088/cjim.12.3.327.


A community pharmacy-based cardiovascular risk screening service implemented in Iran.

Jahangard-Rafsanjani Z, Hakimzadeh N, Sarayani A, Najafi S, Heidari K, Javadi M Pharm Pract (Granada). 2017; 15(2):919.

PMID: 28690693 PMC: 5499348. DOI: 10.18549/PharmPract.2017.02.919.

References
1.
Grundy S, Cleeman J, Daniels S, Donato K, Eckel R, Franklin B . Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol. 2005; 21(1):1-6. DOI: 10.1097/01.hco.0000200416.65370.a0. View

2.
Hosseini M, Carpenter R, Mohammad K . Growth of children in Iran. Ann Hum Biol. 1998; 25(3):249-61. DOI: 10.1080/03014469800005612. View

3.
Sharifi F, Mousavinasab S, Soruri R, Saeini M, Dinmohammadi M . High prevalence of low high-density lipoprotein cholesterol concentrations and other dyslipidemic phenotypes in an Iranian population. Metab Syndr Relat Disord. 2008; 6(3):187-95. DOI: 10.1089/met.2008.0007. View

4.
Hatmi Z, Tahvildari S, Gafarzadeh Motlag A, Kashani A . Prevalence of coronary artery disease risk factors in Iran: a population based survey. BMC Cardiovasc Disord. 2007; 7:32. PMC: 2200651. DOI: 10.1186/1471-2261-7-32. View

5.
Azizi F, Rahmani M, Ghanbarian A, Emami H, Salehi P, Mirmiran P . Serum lipid levels in an Iranian adults population: Tehran Lipid and Glucose Study. Eur J Epidemiol. 2003; 18(4):311-9. DOI: 10.1023/a:1023606524944. View